Review of Pathogenesis of COVID-19: Considerations
C. N. Stanley
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Nigeria.
O. A. Ayodeji
Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital (UPTH), Port Harcourt, Nigeria.
P. C. Stanley *
Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital (UPTH), Port Harcourt, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with a primary target on the human respiratory system. Coronavirus disease was first discovered in Wuhan, China in December 2019 and has currently become a global pandemic. A lot is still unknown about COVID -19 pathogenesis. Prompt assessment, adequate follow up, test and retest of recovered cases to corroborate immune related considerations will go a long way to understand the pathogenesis.
Keywords: COVID -19, SARS-CoV-2, DIC, pathogenesis, Centre for Disease Control (CDC).